NM_002047.4:c.418A>C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002047.4(GARS1):c.418A>C(p.Ile140Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,457,510 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.418A>C | p.Ile140Leu | missense_variant | Exon 3 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.418A>C | p.Ile140Leu | missense_variant | Exon 3 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.316A>C | p.Ile106Leu | missense_variant | Exon 2 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.250A>C | p.Ile84Leu | missense_variant | Exon 4 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.217A>C | p.Ile73Leu | missense_variant | Exon 3 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.49A>C | p.Ile17Leu | missense_variant | Exon 3 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.49A>C | p.Ile17Leu | missense_variant | Exon 4 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*132A>C | non_coding_transcript_exon_variant | Exon 4 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*288A>C | non_coding_transcript_exon_variant | Exon 4 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*288A>C | non_coding_transcript_exon_variant | Exon 4 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.418A>C | non_coding_transcript_exon_variant | Exon 3 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*132A>C | 3_prime_UTR_variant | Exon 4 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000675529.1 | n.*288A>C | 3_prime_UTR_variant | Exon 4 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*288A>C | 3_prime_UTR_variant | Exon 4 of 19 | ENSP00000501884.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457510Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 725420
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces isoleucine with leucine at codon 140 of the GARS protein (p.Ile140Leu). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with GARS-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at